CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CalciMedica, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CalciMedica, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Alafi Capital Co LLC | 10% Owner | – | Aug 24, 2026 | 1 |
| Shaw Allan | Director | – | Aug 21, 2026 | 1 |
| Glicklich Alan | Director | – | Aug 21, 2026 | 2 |
| Guerard Frederic | Director | 90,727 | Aug 21, 2026 | 1 |
| Zaytsev Evgeny | Director | – | Aug 21, 2026 | 2 |
| Wilson Robert N | Director | 1,604,650 | Aug 21, 2026 | 2 |
| Hebbar Sudarshan | Chief Medical Officer | 186,025 | Aug 21, 2026 | 3 |
| Roberts Eric W | CHIEF BUSINESS OFFICER | 366,435 | Aug 21, 2026 | 3 |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | 317,655 | Aug 21, 2026 | 3 |
| Middleton Fred A | Director, 10% Owner | 1,063,272Indirect | Jun 29, 2026 | 1 |
| Bardin Stephen | Chief Financial Officer | 3,000Indirect | Apr 7, 2026 | 1 |
| Dunn Michael J. | President and COO | 11,761 | Apr 7, 2026 | 1 |
| Stauderman Kenneth A. | Chief Scientific Officer | 12,944 | Apr 7, 2026 | 1 |
| Sanderling Venture Partners VI Co Investment Fund LP | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Venture Partners VI LP | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling VI Limited Partnership | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling VI Beteiligungs GmbH & Co KG | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Ventures Management VI | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Ventures VII, L.P. | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Ventures VII Annex Fund, L.P. | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Ventures Management VII | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Sanderling Ventures VII (Canada), L.P. | 10% Owner | 22,479Indirect | Nov 5, 2024 | 0 |
| Bjerkholt Eric | Director | 3,684 | Aug 28, 2024 | 0 |
| Geffken Daniel E. | Interim CFO | – | May 20, 2024 | 0 |
| Valence Investments SPV IV LLC | 10% Owner | 316,109Indirect | May 3, 2023 | 0 |
| Valence Investments SPV V, LLC | 10% Owner | 316,109Indirect | May 3, 2023 | 0 |
| Valence Investments SPV VI, LLC | 10% Owner | 316,109Indirect | May 3, 2023 | 0 |
| Shaffer Christy L | Director | 1,429 | Mar 27, 2023 | 0 |
| Breuil Robert S | Chief Financial Officer | 35,326 | Mar 27, 2023 | 0 |
| Eastland Julia Marie | Director | 1,429 | Mar 27, 2023 | 0 |
| Ackermann Christina | Director | 1,429 | Mar 27, 2023 | 0 |
| Zamiri Parisa | Chief Medical Officer | 28,982 | Mar 27, 2023 | 0 |
| Sauer Dirk | Director | 1,429 | Mar 27, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 (view filing) | Dec 11 | 2 days | Wilson Robert NDirector | PPurchase | +506 | $3.30 | +$1.67K | +0.3%182.2K after | |
| Nov 8, 2023 (view filing) | Nov 7 | 1 day | Leheny A. RachelChief Executive Officer | PPurchase | +2.00K | $3.34 | +$6.68K | +11.9%18.8K after | |
| Nov 8, 2023 (view filing) | Nov 6 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +2.40K | $3.12 | +$7.49K | +7.2%35.9K after | |
| Nov 7, 2023 (view filing) | Nov 3 | 4 days | Roberts Eric WChief Business Officer | PPurchase | +3.70K | $2.77 | +$10.2K | +22.3%20.3K after | |
| Nov 7, 2023 (view filing) | Nov 3 | 4 days | Roberts Eric WChief Business Officer | PPurchase | +11.2K | $2.83 | +$31.8K | +50.6%33.5K after | |
| Nov 7, 2023 (view filing) | Nov 6 | 1 day | Leheny A. RachelChief Executive Officer | PPurchase | +2.44K | $3.12 | +$7.61K | +16.9%16.8K after | |
| Nov 7, 2023 (view filing) | Nov 3 | 4 days | Hebbar SudarshanChief Medical Officer | PPurchase | +36.0K | $2.74 | +$98.6K | +360.0%46.0K after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Roberts Eric WChief Business Officer | PPurchase | +3.20K | $2.80 | +$8.96K | +23.9%16.6K after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Roberts Eric WChief Business Officer | PPurchase | +5.86K | $2.70 | +$15.8K | +35.8%22.2K after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Leheny A. RachelChief Executive Officer | PPurchase | +5.00K | $2.85 | +$14.3K | +53.2%14.4K after | |
| Sep 5, 2023 (view filing) | Aug 29 | 7 days | Roberts Eric WChief Business Officer | PPurchase | +223 | $3.02 | +$673.46 | +4.5%5.22K after | Amended |
| Aug 23, 2023 (view filing) | Aug 21-22 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +2.46K | $3.26 | +$8.02K | +136.9%4.26K after | 2 lots |
| Jun 26, 2023 (view filing) | Jun 23-26 | 3 days | Roberts Eric WChief Business Officer | PPurchase | +700 | $3.40 | +$2.38K | +4.5%16.4K after | 2 lots |
| Jun 26, 2023 (view filing) | Jun 26 | Same day | Roberts Eric WChief Business Officer | PPurchase | +1.20K | $3.70 | +$4.44K | +9.8%13.4K after | |
| Jun 22, 2023 (view filing) | Jun 20-21 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +2.50K | $4.27 | +$10.7K | +19.0%15.7K after | 2 lots |
| Jun 15, 2023 (view filing) | Jun 8 | 7 days | Leheny A. RachelChief Executive Officer | PPurchase | +1.00K | $5.23 | +$5.23K | +12.5%9.00K after | Amended |
| Jun 9, 2023 (view filing) | Jun 9 | Same day | Leheny A. RachelChief Executive Officer | PPurchase | +400 | $5.25 | +$2.10K | +4.5%9.33K after | From original |
| Jun 9, 2023 (view filing) | Jun 9 | Same day | Middleton Fred ADirector, 10% Owner | PPurchase | +714 | $5.20 | +$3.71K | +6.5%11.7K after | |
| Jun 9, 2023 (view filing) | Jun 8 | 1 day | Roberts Eric WChief Business Officer | PPurchase | +485 | $5.20 | +$2.52K | +3.8%13.2K after | |
| Jun 8, 2023 (view filing) | Jun 6-7 | 2 days | Middleton Fred ADirector, 10% Owner | PPurchase | +1.00K | $5.04 | +$5.04K | +10.0%11.0K after | 2 lots |
| Jun 8, 2023 (view filing) | Jun 6-7 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +4.70K | $5.13 | +$24.1K | +58.8%12.7K after | 2 lots |
| Jun 8, 2023 (view filing) | Jun 6-7 | 2 days | Leheny A. RachelChief Executive Officer | PPurchase | +2.00K | $5.19 | +$10.4K | +33.3%8.00K after | 2 lots |
| Jun 5, 2023 (view filing) | Jun 2 | 3 days | Leheny A. RachelChief Executive Officer | PPurchase | +1.00K | $4.80 | +$4.80K | +20.0%6.00K after | |
| Jun 5, 2023 (view filing) | May 16 | 20 days | Leheny A. RachelChief Executive Officer | PPurchase | +1.00K | $2.70 | +$2.70K | New position1.00K after | Amended |
| Jun 5, 2023 (view filing) | Jun 1-2 | 4 days | Roberts Eric WChief Business Officer | PPurchase | +3.69K | $4.64 | +$17.1K | +43.4%12.2K after | 2 lots |
| Jun 1, 2023 (view filing) | May 31 | 1 day | Leheny A. RachelChief Executive Officer | PPurchase | +1.00K | $4.21 | +$4.21K | +25.0%5.00K after | |
| Jun 1, 2023 (view filing) | May 30-31 | 2 days | Bjerkholt EricDirector | PPurchase | +255 | $4.14 | +$1.06K | +7.4%3.68K after | 3 lots |
| Jun 1, 2023 (view filing) | May 30 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +2.00K | $3.86 | +$7.72K | +33.3%8.00K after | |
| May 24, 2023 (view filing) | May 23 | 1 day | Bjerkholt EricDirector | PPurchase | +500 | $3.27 | +$1.64K | +17.1%3.43K after | |
| May 24, 2023 (view filing) | May 23 | 1 day | Leheny A. RachelChief Executive Officer | PPurchase | +3.00K | $3.34 | +$10.0K | +300.0%4.00K after | |
| May 24, 2023 (view filing) | May 22 | 2 days | Roberts Eric WChief Business Officer | PPurchase | +6.00K | $2.95 | +$17.7K | New position6.00K after | |
| May 24, 2023 (view filing) | May 23 | 1 day | Roberts Eric WChief Business Officer | PPurchase | +2.00K | $3.26 | +$6.52K | +30.8%8.50K after | |
| May 22, 2023 (view filing) | May 18-19 | 4 days | Bjerkholt EricDirector | PPurchase | +200 | $2.65 | +$530 | +7.3%2.93K after | 2 lots |
| May 22, 2023 (view filing) | May 19 | 3 days | Middleton Fred ADirector, 10% Owner | PPurchase | +10.0K | $2.85 | +$28.5K | New position10.0K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +3.50K | $2.71 | +$9.48K | New position3.50K after | From original |
| May 18, 2023 (view filing) | May 16 | 2 days | Roberts Eric WCHIEF BUSINESS OFFICER | PPurchase | +1.80K | $2.72 | +$4.90K | New position1.80K after | From original |
| May 18, 2023 (view filing) | May 16-18 | 2 days | Bjerkholt EricDirector | PPurchase | +1.30K | $2.70 | +$3.50K | +91.0%2.73K after | 3 lots |
| May 18, 2023 (view filing) | May 16 | 2 days | Hebbar SudarshanChief Medical Officer | PPurchase | +10.0K | $2.70 | +$27.0K | New position10.0K after | |
| Apr 4, 2022 (view filing) | Mar 31 | 4 days | Breuil Robert SChief Financial Officer | SSale | −2.19K | $1.25 | −$2.73K | −9.6%20.5K after | |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | Breuil Robert SChief Financial Officer | SSale | −7.28K | $3.55 | −$25.9K | −36.4%12.7K after |